Assessment of Exercise Intensity in Cardiac Rehabilitation Programmes for Patients With Chronic Heart Failure
Cardiac rehabilitation is the ideal comprehensive intervention for patients with chronic heart failure (CHF), since it addresses the complex interplay of medical, psychological and behavioural factors facing these individuals. Structured exercise training within a cardiac rehabilitation programme is firmly recommended for these patients. However, it is questionable whether patients are achieving an adequate dose of exercise to provide optimal benefits. The essential components for setting optimal training include the appropriate mode, duration, frequency and intensity of exercise. UK surveys of cardiac rehabilitation describe the frequency and duration of training, but here is scant information on exercise intensity. However, it is apparent that randomised controlled trials of exercise training use doses more than 4 times greater than in UK current practice. The Eastbourne Exercise Cardiology Research Group has demonstrated that although patients benefit from improved quality of life and submaximal fitness after a hospital outpatient cardiac rehabilitation programme, they do not achieve the increases in important prognostic indicators reported by the majority of exercise training trials.
The critical factor in terms of eliciting a sufficient training effect while minimising risk is the intensity of the exercise performed. It is now widely accepted that the traditional methods of using fixed percentages of maximal heart rate or oxygen uptake to set exercise intensity include serious errors. The European Society of Cardiology recommends that cardiopulmonary exercise testing should be used to provide an objective evaluation of the metabolic demand of exercise. This allows physiologically meaningful reference points to be established for aerobic exercise prescription and is the solution to defining safe and effective training intensities. The next step is to determine whether this information can be transferred to a practical cardiac rehabilitation environment to set and monitor exercise intensity
Panoramica dello studio
Stato
Condizioni
Descrizione dettagliata
Background Heart failure is a chronic, costly and life-threatening disorder that constitutes a significant burden for individuals and the National Health Service [There are 27,000 new cases reported per annum in the UK. Cardiac rehabilitation (CR) is recommended as the ideal comprehensive intervention since it addresses the complex interplay of medical, psychological and behavioural factors facing CHF patients and carers.
Study Aim Primary objective to describe the exercise intensity, defined by oxygen uptake (VO2) in terms of the individual physiological thresholds, in CHF patients undergoing CR according to current guidelines Primary end point: VO2 Secondary objectives Secondary objectives of this study are:-
- To measure resting and exercising energy expenditure in order to a) establish the value of 1 MET (resting metabolic rate) for patients with CHF, and b) to establish the MET value (defined as multiples of resting metabolic rate) for exercises performed in CR sessions
- To measure affective responses (feeling very bad - feeling very good; levels of energy - tiredness and tension - calmness) to exercise during CR sessions
- To measure weekly physical activity level in CHF patients undergoing Phase III and IV CR.
For the secondary analysis the following secondary end points and parameters will be established
- MET values, defined as multiples of resting oxygen uptake or resting metabolic rate (1 MET), for different CR exercises
- Ratings of affective response on the Feelings Scale (FS) and ratings of perceived activation on the Felt Arousal Scale (FAS).
- Average daily activity over 7 day period in terms of steps per day and periods spent sitting, standing and walking
Tipo di studio
Iscrizione (Anticipato)
Contatti e Sedi
Luoghi di studio
-
-
East Sussex
-
Eastbourne, East Sussex, Regno Unito, BN21 2UD
- Eastbourne General Hospital
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Descrizione
Inclusion criteria:
- Systolic heart failure with resting left ventricular ejection fraction below 40%
- New York Heart Association (NYHA) class I-III
- clinically stable for at least 4 weeks on optimised medication dosage according to current guidelines
Exclusion criteria:
- Acute coronary syndrome within past 6 months
- Untreated lifethreatening cardiac arrhythmias
- Acute heart failure (during initial period of haemodynamic instability)
- Uncontrolled hypertension
- Advanced atrioventricular block
- Acute myocarditis or pericarditis
- Symptomatic aortic stenosis
- Severe hypertrophic obstructive cardiomyopathy
- Acute systemic illness Intracardiac thrombus
- Progressive worsening of exercise tolerance of dyspnoea at rest over previous 35 days
- Significant ischaemia during low intensity exercise (< 2 METS, < 50W)
- Uncontrolled diabetes
- Recent embolism
- Thrombophlebitis
- New onset atrial fibrillation/flutter
- > 1.8 kg increase in body mass over previous 13 days
- Concurrent, continuous or intermittent dobutamine therapy
- Decrease in systolic blood pressure with exercise
- NYHA Functional Class IV
- Complex ventricular arrhythmia at rest or appearing with exertion
- Supine resting heart rate > 100 beats/min
- Patient is participating in a conflicting study, is unable to perform exercise testing
- Patient lacks the capacity to consent or cannot comply with study requirements
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Lasso di tempo |
|---|---|
|
The primary outcome measure is the oxygen uptake(VO2)during exercise
Lasso di tempo: 13 weeks
|
13 weeks
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Affective responses (e.g. feelings of pleasure/displeasure)
Lasso di tempo: 13 weeks
|
Questionnaire used to measure affective responses (Feelings Scale, Felt Anxiety Scale and Activation/Deactivation )
|
13 weeks
|
|
Weekly physical activity
Lasso di tempo: 13 weeks
|
Average daily physical activity: Participants' freeliving activity will be classified by ActivPAL into periods spent sitting, standing and walking, and daily energy expenditure will also be estimated from this information.
|
13 weeks
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Guy W Lloyd, MD, Eastbourne General Hospital
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Anticipato)
Completamento dello studio (Anticipato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- TN11-26
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Insufficienza cardiaca
-
Assiut UniversityNon ancora reclutamentoCardiac CT TOF
-
Rush University Medical CenterCompletatoAdvanced Cardiac Life Support, rianimazione cardiopolmonare, volume corrente, ventilazione manualeStati Uniti